We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current OPTI market cap is 5.96M. The company's latest EPS is USD -0.0004 and P/E is 0.00.
| Year End 31 December 2022 | 2019 | 2020 | 2021 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 112k | 1.01M | 31.09M | 21.06M | 2.19M |
| Operating Income | -191k | -85k | 11.79M | -11.07M | -547k |
| Net Income | -5.41M | -1.2M | 11.55M | -11.53M | -1.35M |
| Year End 31 December 2022 | 2019 | 2020 | 2021 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.05M | 974k | 32.51M | 17.31M | 17.32M |
| Total Liabilities | 6.81M | 7.41M | 17.08M | 15.55M | 16.01M |
| Total Equity | -5.76M | -6.44M | 15.43M | 1.76M | 1.31M |
| Year End 31 December 2022 | 2019 | 2020 | 2021 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -1.42M | -511k | -8.4M | 8.8M | -2.49M |
| Investing | -713k | N/A | -1.52M | -6.68M | 1.13M |
| Financing | 2.1M | 516k | 10.32M | -6.68M | 901k |
| Market Cap | 5.96M |
| Price to Earnings Ratio | 0.00 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 3.73B |
| Average Volume (1 week) | 1.68M |
| Average Volume (1 Month) | 1.63M |
| 52 Week Change | 45.45% |
| 52 Week High | 0.0047 |
| 52 Week Low | 0.0002 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Optec International Inc (CE) |
| Address |
412 north main street buffalo, new york 82834 |
| Website | https://www.optecinternational.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
